#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 29

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Pulmonary arterial hypertension

Not recruiting

InvestigationalNo placebo

A Study of PF-07868489 Safety and Effectiveness in Adults with Pulmonary Arterial Hypertension Who Participated in a Previous PF-07868489 Trial

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:PF-07868489

Contact Research Centre

Dementia Alzheimer's type

Not recruiting

InvestigationalNo placebo

A Study to Test the Long-term Safety and Benefits of GSK4527226 in Patients with Early Alzheimer's Disease

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Gsk4527226

Contact Research Centre

Chronic kidney disease+1

Not recruiting

Investigational

A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Ziltivekimab

Contact Research Centre

Acute myocardial infarction

Not recruiting

Investigational

A study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Ziltivekimab

Contact Research Centre

Migraine

Not recruiting

Registered drug

Study of rimegepant for preventing chronic migraine in adolescents aged 12 to 17 years

Registered drug

Italy

Participants:0–17 years

Contact Research Centre

Cardiac amyloidosis

Not recruiting

Registered drugNo placebo

Long-term safety study of NNC6019-0001 for patients with transthyretin amyloid cardiomyopathy (ATTR-CM)

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Codeine Phosphate

Contact Research Centre

Waldenstrom's macroglobulinaemia+1

Not recruiting

InvestigationalNo placebo

Evaluating Sonrotoclax Alone and Combined with Zanubrutinib for Patients with Previously Untreated or Relapsed/Refractory Waldenström Macroglobulinemia

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Zanubrutinib

Contact Research Centre

Cardiac amyloidosis

Not recruiting

Investigational

Study on the Effects and Safety of Coramitug for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR CM)

Investigational

Italy

Participants:18–64 years · 65+ years

Contact Research Centre

Chronic spontaneous urticaria

Not recruiting

Registered drug

Study on the Effects of EVO756 in Adults with Moderate to Severe Chronic Spontaneous Urticaria

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Placebo

Contact Research Centre

Epileptic encephalopathy

Not recruiting

Investigational

Title: Study of LP352 (bexicaserin) oral solution versus placebo for treating seizures in children and adults with Developmental and Epileptic Encephalopathies

Investigational

Italy

Participants:0–17 years · 18–64 years · 65+ years

Contact Research Centre

Study on the Immune Response and Safety of RSVPreF3 Vaccine in Adults 18+ with Lung or Kidney Transplants at Risk of RSV Infections, Compared to Healthy Adults 50+

Not recruiting

Registered drugNo placebo

Study on the Immune Response and Safety of RSVPreF3 Vaccine in Adults 18+ with Lung or Kidney Transplants at Risk of RSV Infections, Compared to Healthy Adults 50+

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E

Contact Research Centre

Chronic graft versus host disease

Not recruiting

InvestigationalNo placebo

Study Comparing Axatilimab to Best Available Therapy for Patients with Chronic Graft-Versus-Host Disease After Two or More Treatments

InvestigationalNo placebo

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Axatilimab

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.